Mining and Metals
Silver Scott Mines, Inc. (OTC Pink:SILS)
Interview with Stuart Fine, CEO […]
Month: August 2025
News Feed
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of […]
Mining and Metals
Endurance Gold Corporation (TSXV: EDG) (OTCQB: ENDGF) (FSE: 3EG)
Endurance Gold Corporation is a company focused on the acquisition, exploration and development of highly prospective North American mineral properties with the potential to develop world-class deposits.
CEO Interviews
Battery X Metals (CSE: BATX) (OTCQB: BATXF)
Interview with Massimo Bellini Bressi, CEO […]
CEO Interviews
Regenerative Medical Technology (OTC: RMTG) Dave Christensen, CEO and President
Interview with Dave Christensen, CEO and President
[…]
News Feed
C-COM Receives $2 Million Antenna Orders
Ottawa, Ontario–(Newsfile Corp. – August 12, 2025) – C-COM Satellite Systems Inc., (TSXV: CMI) (OTCQB: CYSNF) a leading global provider of commercial grade mobile auto-deploying satellite antenna systems, announced today that it has received $2 […]
News Feed
Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) — MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential […]
News Feed
Midnight Sun Initiates Drilling at Flagship Dumbwa Target
The program marks the first systematic drill program carried out across Dumbwa – following up on the ~20-kilometre Dumbwa copper-in-soil anomaly and recent dipole-dipole IP Survey. August 06, 2025 6:30 AM EDT | Source: Midnight Sun […]
News Feed
Biological Efficacy Demonstrated in a Phase 2 Clinical Trial of SGX945 for the treatment of Behçet’s Disease
Study results support advancing SGX945 in this difficult to treat orphan disease PRINCETON, N.J., July 31, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products […]